Moreover, the brain microenvironment induces a loss of PTEN expression in metastatic melanoma cells, leading to an increased secretion of CCL2 and a subsequent recruitment of myeloid cells that enhance the outgrowth of brain metastatic melanoma cells via enhanced proliferation and reduced apoptosis [73]. The gene discussed is PTEN; the disease is melanoma.